TFS Financial CORP current report, 11 August 2008

TFS Financial Corp 8-K Summary

Business Context and Reporting Period

This Form 8-K was filed by TFS Financial Corporation on August 13, 2008, reporting events occurring on August 11, 2008. The filing addresses Item 5.02 regarding compensatory arrangements for certain officers and directors under the 2008 Equity Incentive Plan.

Key Financial Metrics

The filing text does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on equity compensation grants.

Material Changes

The primary material event is the approval and granting of stock options and restricted stock units (RSUs) to executive officers and directors. The total grants to all associates included 4,133,575 options and 1,280,950 RSUs.

Guidance, Outlook, and Management Commentary

The filing details the terms of the equity awards:

  • Exercise Price: Stock options were granted with an exercise price of $11.74 per share, based on the closing stock price on August 11, 2008.
  • Executive Vesting: Options vest 25% annually over four years (years 4-7). RSUs vest 10% annually over seven years (years 3-9) with a 30% cliff in year 10.
  • Director Vesting: Directors (excluding Marc A. Stefanski and Marianne Piterans) received 50,000 RSUs each, vesting in equal installments over five years starting August 11, 2009.
  • Acceleration: Vesting accelerates upon death, disability, retirement, or a change in control.
  • Dividend Rights: RSUs include dividend equivalent rights payable in cash.

Investor Verification Checklist

  • Verify the total number of shares authorized under the 2008 Equity Incentive Plan to assess remaining capacity for future grants.
  • Confirm the dilution impact of the 4,133,575 options and 1,280,950 RSUs granted to associates.
  • Review the specific definitions of "retirement" and "change in control" in the attached Exhibits 10.1, 10.2, and 10.3 to understand acceleration triggers.
  • Check the company's stock price performance relative to the $11.74 exercise price to determine if the options are currently in-the-money.